au.\*:("ALDRED K")
Results 1 to 10 of 10
Selection :
OCCURRENCES OF GALENA AND OTHER MINERALS IN THE AREA WEST OF MANSFIELD, NOTTINGHAMSHIRE.ALDRED K.1969; MERCIAN GEOLOGIST; GBR; 1969(1), VOL. 3, NUM. 0001, P. 35 A 38Miscellaneous
Increased proximal tubule NHE-3 and H+-ATPase activities in spontaneously hypertensive ratsALDRED, K. L; HARRIS, P. J; EITLE, E et al.Journal of hypertension. 2000, Vol 18, Num 5, pp 623-628, issn 0263-6352Article
Aspirin-induced acute gastric mucosal injury is a neutrophil-dependent process in ratsMAKAU LEE; ALDRED, K; LEE, E et al.American journal of physiology. Gastrointestinal and liver physiology. 1992, Vol 26, Num 6, pp G920-G926, issn 0193-1857Article
Importance of gastric acid in gastric ulcer formation in rabbits with antibody-induced prostaglandin deficiencyLEE, M; ALDRED, K; LEE, E et al.Gastroenterology (New York, NY. 1943). 1992, Vol 103, Num 5, pp 1467-1474, issn 0016-5085Article
Differential effects of a novel non-peptide endothelin receptor antagonist (bosentan) in rat liver and vasculaturePHILLIPS, P. A; RISVANIS, J; ALDRED, K et al.Clinical science (1979). 1995, Vol 89, Num 6, pp 575-579, issn 0143-5221Article
Vasoconstrictor responses to components of the renin-angiotensin system in cyclosporin-induced hypertension in the ratROLLS, K. A; PHILLIPS, P. A; ALDRED, K et al.Clinical and experimental pharmacology and physiology. 1994, Vol 21, Num 3, pp 227-230, issn 0305-1870Conference Paper
Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the ratBURRELL, L. M; PHILLIPS, P. A; RISVANIS, J et al.American journal of physiology. Heart and circulatory physiology. 1998, Vol 44, Num 1, pp H176-H182, issn 0363-6135Article
Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonismBURRELL, L. M; PHILLIPS, P. A; RISVANIS, J et al.Hypertension (Dallas, Tex. 1979). 1995, Vol 26, Num 5, pp 828-834, issn 0194-911XArticle
Vascular endothelin responsiveness and receptor characteristics in vitro and effects of endothelin receptor blockade in vivo in cyclosporin hypertensionPHILLIPS, P. A; ROLLS, K. A; BURRELL, L. M et al.Clinical and experimental pharmacology and physiology. 1994, Vol 21, Num 3, pp 223-226, issn 0305-1870Conference Paper
Modulation of genetic hypertension by short-term AVP V1A or V2 receptor antagonism in young SHRNAITOH, M; BURRELL, L. M; RISVANIS, J et al.American journal of physiology. Renal, fluid and electrolyte physiology. 1997, Vol 41, Num 2, pp F229-F234, issn 0363-6127Article